Carl L Gordon insider trades
Open-market stock purchases and sales by Carl L Gordon, Director, 10% Owner at ADARx Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 30, 2010.
Track record: 41% of 32 scored buys are up 5% or more since purchase, averaging +11%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought | $5.1M |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought | $1M |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought | $10M |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc | Bought (not open market) | — |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc | Bought (not open market) | — |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc | Bought (not open market) | — |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc | Bought (not open market) | — |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc | Bought | $5M |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc | Bought (not open market) | — |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc | Bought | $15M |
Companies traded
- ADRX ADARx Pharmaceuticals, Inc: 3 buys, last Sep 28, 2026
- ETRA Electra Therapeutics, Inc: 2 buys, last Sep 21, 2026
- BLSM BlossomHill Therapeutics, Inc: 1 buy, last Aug 10, 2026
- SCTX Scribe Therapeutics, Inc: 1 buy, last Jul 27, 2026
- CMPX Compass Therapeutics, Inc: 9 buys, 1 sale, last Jan 2, 2026
- KROS Keros Therapeutics, Inc: 1 buy, 2 sales, last Nov 21, 2025
- MBX MBX Biosciences, Inc: 6 buys, last Feb 18, 2025
- NONE Lomond Therapeutics Holdings, Inc: other filings, last Nov 1, 2024
- ACET Adicet Bio, Inc: 7 buys, last Aug 21, 2024
- TERN Terns Pharmaceuticals, Inc: 9 buys, 6 sales, last Jul 16, 2024
- KNTE Kinnate Biopharma Inc: 18 buys, last Apr 3, 2024
- THRX Theseus Pharmaceuticals, Inc: 12 buys, last Feb 14, 2024